Moonlight AI, a Swiss developer of diagnostic image-analysis tools, raised $3.3 million in private financing to expand its library of whole-slide cytopathology images linked to genomic data. The company plans to hire and accelerate programs in myelodysplastic syndrome, non-small cell lung cancer, and chronic lymphocytic leukemia. Its software targets identification of genomic biomarkers and disease signatures from routine imaging of blood and cytology smears. The funding is intended to strengthen clinical partnerships with hospitals and laboratories that can supply both image and molecular context. The round underscores continued investor interest in computational pathology approaches that connect routinely collected slides to actionable molecular readouts.